Paper32808233
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
De Sutter PJ and 6 others. Clin Pharmacokinet, 2020. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019. Papers, record 32808233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32808233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Pharmaceutical Preparations | Major topic |
| Pharmacokinetics | Major topic |
| Body Composition | |
| Humans |
Source PubMed
References164
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11237938 | Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. | Am J Clin Nutr | 2001 | https://conductscience.org/library/papers/11237938 | PubMed |
| 2 | 17216337 | Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. | Dig Dis Sci | 2007 | https://conductscience.org/library/papers/17216337 | PubMed |
| 3 | 18511651 | Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. | J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18511651 | PubMed |
| 4 | 28335648 | Inflammation and pharmacokinetics: potential implications for HIV-infection. | Expert Opin Drug Metab Toxicol | 2017 | https://conductscience.org/library/papers/28335648 | PubMed |
| 5 | 23945604 | Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. | CPT Pharmacometrics Syst Pharmacol | 2013 | https://conductscience.org/library/papers/23945604 | PubMed |
| 6 | 18079757 | Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18079757 | PubMed |
| 7 | 16678035 | Therapeutic drug monitoring of prednisolone after lung transplantation. | J Heart Lung Transplant | 2006 | https://conductscience.org/library/papers/16678035 | PubMed |
| 8 | 14506027 | Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14506027 | PubMed |
| 9 | 14624363 | The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. | Pflugers Arch | 2004 | https://conductscience.org/library/papers/14624363 | PubMed |
| 10 | 30191579 | Liver Disease in Cystic Fibrosis: Illuminating the Black Box. | Hepatology | 2019 | https://conductscience.org/library/papers/30191579 | PubMed |
| 11 | 10485301 | Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis. | Eur J Pediatr | 1999 | https://conductscience.org/library/papers/10485301 | PubMed |
| 12 | 12548141 | Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis. | Ther Drug Monit | 2003 | https://conductscience.org/library/papers/12548141 | PubMed |
| 13 | 23887688 | Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods. | CPT Pharmacometrics Syst Pharmacol | 2013 | https://conductscience.org/library/papers/23887688 | PubMed |
| 14 | 17485505 | Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17485505 | PubMed |
| 15 | 17576827 | Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17576827 | PubMed |
| 16 | 23357842 | Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis. | Int J Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23357842 | PubMed |
| 17 | 11396809 | Assessment of hepatic function in cystic fibrosis by lidocaine metabolism. | J Pediatr Gastroenterol Nutr | 2001 | https://conductscience.org/library/papers/11396809 | PubMed |
| 18 | 9812180 | Drug disposition in cystic fibrosis. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9812180 | PubMed |
| 19 | 3286083 | Clinical pharmacokinetics of aztreonam. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3286083 | PubMed |
| 20 | 9174484 | Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. | Am J Clin Nutr | 1997 | https://conductscience.org/library/papers/9174484 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897405 | Predictive Performance of pyDarwin-Selected Versus Expert-Developed Paediatric Tobramycin Population Pharmacokinetic Models for Model-Informed Precision Dosing. | AAPS J | 2026 | https://conductscience.org/library/papers/42897405 | PubMed |
| 42170795 | Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42170795 | PubMed |
| 40957819 | Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI). | J Cyst Fibros | 2026 | https://conductscience.org/library/papers/40957819 | PubMed |
| 40698812 | Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40698812 | PubMed |
| 40312342 | Clinical Study Reports-a systematic review with thematic synthesis: Part 2. Studying benefits, harms, and the benefit to harm balance of pharmacological interventions. | Trials | 2025 | https://conductscience.org/library/papers/40312342 | PubMed |
| 40254714 | Anti-infectives in Pediatric Patients with Cystic Fibrosis: A Comprehensive Review of Population Pharmacokinetic Analyses. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40254714 | PubMed |
| 40142982 | Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40142982 | PubMed |
| 39846711 | The Pharmacokinetic Changes in Cystic Fibrosis Patients Population: Narrative Review. | Medicines (Basel) | 2024 | https://conductscience.org/library/papers/39846711 | PubMed |
| 39581957 | Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis. | Clin Pharmacokinet | 2024 | https://conductscience.org/library/papers/39581957 | PubMed |
| 39526586 | Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis. | Pediatr Pulmonol | 2025 | https://conductscience.org/library/papers/39526586 | PubMed |
| 38303579 | Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patients. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/38303579 | PubMed |
| 37760696 | Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37760696 | PubMed |
| 37148427 | MicroRNAs from Holarrhena pubescens stems: Identification by small RNA Sequencing and their Potential Contribution to Human Gene Targets. | Funct Integr Genomics | 2023 | https://conductscience.org/library/papers/37148427 | PubMed |
| 36565357 | Linezolid pharmacokinetics: a systematic review for the best clinical practice. | Eur J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/36565357 | PubMed |
| 35748042 | Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35748042 | PubMed |
| 35625789 | Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625789 | PubMed |
| 35292968 | Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19. | Clin Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35292968 | PubMed |
| 35280373 | Population pharmacokinetics of polymyxin B: a systematic review. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35280373 | PubMed |
| 35214140 | Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35214140 | PubMed |
| 35119624 | "De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug Monitoring. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35119624 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32808233
GET https://conductscience.org/api/papers/v1/32808233/references?page=2